This content is from: Premium Hedge Funds Went Bottom Fishing and Found These Gems Several hedge funds, including Melvin, Adage and EcoR1, have made some potentially savvy buys in the past few weeks. By Steve Taub April 01, 2020
This content is from: Premium Hedge Funds Surface in Wave of Biopharma SPAC Deals RTW and Perceptive Advisors are among investors seen in recent SPAC deals in biopharma. By Stephen Taub October 19, 2020
This content is from: Premium Another SPAC With Magnetar Ties Hunts for a Merger Partner A SPAC sponsored by Magnetar has filed IPO plans just two weeks after the hedge fund firm’s first blank-check company this year announced a merger agreement. By Steven Taub December 22, 2020
This content is from: Premium A New Biotech Fund for Suvretta Averill will be completely separate from Suvretta’s existing funds but share the firm’s infrastructure. By Stephen Taub February 21, 2020
This content is from: Premium Unicorn Comeback Helps Tiger Global, Viking, Valiant, and Others After the IPOs crashed last year, a turnaround is in the offing. By Michelle Celarier January 28, 2020
This content is from: Premium Hedge Funds Are Long These Three SPAC Deals Soroban has a stake in Bill Ackman’s Pershing Square Tontine, while DraftKings and Nikola have attracted hedge funds including Hudson Bay. By Michelle Celarier August 17, 2020
